[1]
P. SANDEEP and K. ILANGO 2022. A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR. Journal of Pharmaceutical Negative Results. (Nov. 2022), 217–225. DOI:https://doi.org/10.47750/pnr.2022.13.S09.026.